Articles published in Advances in Pharmacoepidemiology and Drug Safety have been cited by esteemed scholars and scientists all around the world. Advances in Pharmacoepidemiology and Drug Safety has got h-index 14, which means every article in Advances in Pharmacoepidemiology and Drug Safety has got 14 average citations.

Following are the list of articles that have cited the articles published in Advances in Pharmacoepidemiology and Drug Safety.

  2022 2021 2020 2019 2018

Year wise published articles

30 32 23 3 4

Year wise citations received

71 95 59 87 69
Journal total citations count 654
Journal Impact Factor 2.86
Journal 5 years Impact Factor 4.33
Journal CiteScore 5.34
Journal h-index 14
Important citations

Padhy J, Lakshmi KA. Research and Reviews: Journal of Pharmacognosy and Phytochemistry.

Lu DY. HAART in HIV/AIDS Treatments, a Current Limitation. EC Orthopaedics. 2017;6:140-6.

Lu DY, Lu TR, Chen EH, Yarla NS, Xu B, Ding J, Huang M, Zhu H. Keep u p the pace of drug development evolution and expenditure. Cancer Rep Rev. 2018 Sep 26;2(5):165.

Lu DY, Lu TR, Wu HY, Yarla NS, Ding J, Xu B. HIV/AIDS Curable Study: New Forms of Therapeutic Trinity. Recent patents on anti-infective drug discovery. 2018 Nov 1;13(3):217-27.

Wu JD, Lu Y, Zhu H. Type 2 Diabetes Preventions, Treatments and New Drug Developments.

Lu DY, Che JY, Yarla NS, Wu HY, Lu TR, Xu B, Wu SY, Ding J, Lu Y, Zhu H. Type 2 diabetes treatment and drug development study. The Open Diabetes Journal. 2018 Aug 31;8(1).

Lu DY, Lu TR, Lu Y, Wu HY, Yarla NS. The acquisition of mathematical language in biomedical articles. J Cell Developmental Biol. 2017;1(1):8.

Lu DY, Lu TR, Chen EH, Xu B, Yarla NS, Zhu H, Ding J. Anticancer drug development, system updating and global participations. Current Drug Therapy. 2017 Jan 1;12:37-45.

Lu D, Lu T, Zhu H, Ding J, Xu B, Wu HY, Wu SY, Yarla NS. Anticancer drug development, getting out from bottleneck. Med Chem (Los Angeles). 2017;7:739-44.

Lu DY, Lu TR, Yarla NS, Wu HY, Xu B, Ding J, Zhu H. Drug combination in clinical cancer treatments. Reviews on recent clinical trials. 2017 Sep 1;12(3):202-11.

Lu DY, Wu HY, Yarla NS, Xu B, Ding J, Lu TR. HAART in HIV/AIDS Treatments: Future Trends. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders). 2018 Mar 1;18(1):15-22.

Lu DY, Lu TR, Xu B, Qi RX, S Yarla N, Zhou XD, Ding J. Cancer metastasis, a clinical dilemma for therapeutics. Current Drug Therapy. 2016 Aug 1;11(2):163-9.

Lu DY, Wu HY, Lu TR, Che JY, Lu Y. Updating biomedical studies by recruiting more mathematics or physics-majored talents. Metabolomics. 2016;6(2):e148.

Md S. A Review on the Quality Control Analysis of Oral Dosage Form: Tablets. Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences. 2016.

Nathani S. Research & Reviews: Journal of Pharmaceutics and Nanotechnology A Review on Targeted Drug Delivery System-Nanoparticles. 2016.

Muntha P. Advancements in Drug Delivery Systems: Novel Technologies & Formulations. Research and Reviews: Journal of Pharmaceutical Analysis. 2016.

Varghese S, Anil A, Scaria S, Abraham E. Nanoparticulate Technology in the treatment of Tuberculosis: A Review. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH. 2018;9:4109-4116.

Lu DY, Lu TR, Wu HY, Yarla NS, Ding J, Xu B. HIV/AIDS Curable Study: New Forms of Therapeutic Trinity. Recent patents on anti-infective drug discovery. 2018;13:217-227.

Lu DY, Wu HY, Yarla NS, Xu B, Ding J, Lu TR. HAART in HIV/AIDS Treatments: Future Trends. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders). 2018 Mar 1;18:15-22.

Alomi YA, Alghamdi SJ, Alattyh RA. National Workload Analysis of Network of Drug Information Centers at Ministry of Health Hospitals in Saudi Arabia. International Journal of Pharmacy and Health Sciences. 2018;1.